NCT01950624

Brief Summary

The goal of this study is to develop a registry for Down syndrome (DS) to facilitate research participation by individuals with Down syndrome. DS-Connect® is an online survey tool designed to collect demographic data and health information from individuals with DS. It is open to all people with Down syndrome. The purposes of DS-Connect® are:

  1. 1.To identify the various phenotypic manifestations of DS.
  2. 2.To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
111mo left

Started Sep 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Sep 2013Jun 2035

Study Start

First participant enrolled

September 6, 2013

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 21, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 25, 2013

Completed
21.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2035

Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

21.7 years

First QC Date

September 21, 2013

Last Update Submit

January 29, 2025

Conditions

Keywords

Patient RegistryDown SyndromeNatural History

Outcome Measures

Primary Outcomes (2)

  • To determine the prevalence of the various co-occurring conditions in Down syndrome.

    Participants in DS-Connect® will complete health history surveys regarding medical diagnoses and can update the surveys annually or whenever their health changes.

    Through study completion, up to 10 years

  • Facilitate participation in research for individuals with DS who may be eligible for research studies or new clinical trials.

    Participants may choose to hear about Down syndrome research studies that may be relevant to their co-occurring conditions.

    Through study completion, up to 10 years

Secondary Outcomes (1)

  • Enable aggregate data sharing from individuals with Down syndrome.

    Through study completion, up to 10 years

Study Arms (1)

Down syndrome cohort

Individuals who have a diagnosis of complete trisomy 21, translocation Down syndrome or mosaic Down syndrome.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with DS (including those with mosaic DS and partial trisomy 21).

You may qualify if:

  • Adults (at least 18 years of age) with a diagnosis of DS (including mosaic DS or partial trisomy 21) who are capable of providing consent to participate, or for whom a legally authorized representative (LAR) may give permission on behalf of the individual to participate. Adults with DS who cannot consent for themselves but can provide assent would need to provide assent to their LAR.
  • Children (up to age 18 years of age) with a diagnosis of DS. Parents/guardians may enter registry information and give permission to participate on behalf of their child; if the child is over 7 years of age and able to provide assent, they must do so. (Note: Once a child has reached age 18, he or she will be prompted to re-enroll into the registry as an adult, if he/she is able to provide informed consent or with the consent of his/her LAR if unable to re-enroll themselves.)
  • No individuals with DS will be excluded from taking part in DS-Connect based on age, race, ethnicity, or gender.

You may not qualify if:

  • A person who does not have a diagnosis of DS (or mosaic DS or partial trisomy 21)
  • Adults with DS who are not capable of providing informed consent or assent to participate and do not have a Legally Authorized Representative who can do so. In the case where an adults with DS is able to provide assent but does not do so, that adult will be excluded.
  • A participant, parent, and/or LAR who cannot provide consent or does not read or understand a language that is available for the registry, either English or Spanish.
  • A child with DS (between the ages of 7 and 18 years) who is capable of providing assent but does not do so.
  • A child under the age of 18 years whose parents share joint custody and one parent indicates that they do not consent to the child's participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linda Crnic Institute for Down Syndrome

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Down Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Officials

  • Joaquin M Espinosa, Ph.D.

    Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Angela Rachubinski, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2013

First Posted

September 25, 2013

Study Start

September 6, 2013

Primary Completion (Estimated)

June 1, 2035

Study Completion (Estimated)

June 1, 2035

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

IPD will be available to other researchers through the INCLUDE Data Hub.

Locations